Anika Therapeutics Inc

10-Year Study

ANIK.US · Healthcare · US · Common Stock

Executive Summary: Anika Therapeutics Inc has compounded at -10.7% annually over the last 10 years, with a maximum drawdown of 88.3% and an annualized volatility of 43.6%.

1Y CAGR
+42.1%
3Y CAGR
-17.6%
5Y CAGR
-20.2%
10Y CAGR
-10.7%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
88.3%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
-0.14
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
-0.22
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
43.2%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +60.1%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · -41.6%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
30%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-4.055.61.06.1————————60.1%
20253.62.3-13.9-3.3-23.3-5.1-22.013.60.23.71.3-2.7-41.6%
20243.83.24.61.9-0.9-1.27.6-5.7-3.9-30.73.6-7.1-27.4%
20234.82.2-9.4-10.75.6-4.1-10.2-23.54.44.712.43.4-23.4%
2022-11.22.2-22.7-14.31.02.74.7-3.35.319.411.0-6.2-17.4%
2021-18.2-0.811.1-1.516.1-7.2-7.37.5-1.3-2.1-6.1-8.4-20.8%
2020-20.71.6-30.814.90.912.5-3.55.3-7.7-7.815.919.7-12.7%
201913.0-14.1-7.35.319.36.935.63.0-3.328.2-17.9-10.354.3%
201823.8-22.0-4.5-11.5-7.6-21.325.13.41.9-15.2-3.7-2.4-37.7%
20173.2-7.4-7.26.20.36.63.75.08.0-5.80.9-2.210.1%
2016———2.13.613.4-7.0-5.41.3-7.35.24.99.5%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 43.6%. The dominant macroeconomic risk driver is QUAL.US, accounting for 18.3% of variance. Idiosyncratic stock-specific factors contribute 37.7%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2016-03-0110000
2016-04-0110210.196779964223
2016-05-0110581.39534883721
2016-06-0111996.869409660107
2016-07-0111162.790697674418
2016-08-0110563.506261180679
2016-09-0110699.910554561719
2016-10-019919.499105545618
2016-11-0110433.81037567084
2016-12-0110948.121645796065
2017-01-0111301.431127012522
2017-02-0110462.880143112701
2017-03-019713.774597495527
2017-04-0110315.295169946334
2017-05-0110346.60107334526
2017-06-0111033.094812164582
2017-07-0111440.071556350626
2017-08-0112008.050089445438
2017-09-0112969.588550983899
2017-10-0112216.010733452596
2017-11-0112325.581395348838
2017-12-0112055.008944543828
2018-01-0114919.499105545618
2018-02-0111639.087656529517
2018-03-0111118.067978533096
2018-04-019841.2343470483
2018-05-019092.128801431127
2018-06-017155.635062611807
2018-07-018951.252236135957
2018-08-019255.36672629696
2018-09-019432.021466905187
2018-10-017996.422182468695
2018-11-017703.488372093024
2018-12-017515.652951699463
2019-01-018495.080500894455
2019-02-017296.511627906977
2019-03-016762.075134168157
2019-04-017122.093023255815
2019-05-018497.316636851521
2019-06-019083.184257602861
2019-07-0112318.87298747764
2019-08-0112692.307692307691
2019-09-0112274.150268336314
2019-10-0115740.161001788909
2019-11-0112924.865831842575
2019-12-0111594.364937388193
2020-01-019192.754919499106
2020-02-019338.103756708408
2020-03-016464.669051878354
2020-04-017430.679785330948
2020-05-017497.763864042934
2020-06-018436.940966010734
2020-07-018139.53488372093
2020-08-018571.109123434704
2020-09-017913.6851520572445
2020-10-017294.275491949909
2020-11-018452.593917710195
2020-12-0110120.751341681573
2021-01-018275.939177101967
2021-02-018206.618962432916
2021-03-019121.198568872987
2021-04-018984.79427549195
2021-05-0110431.574239713775
2021-06-019680.232558139536
2021-07-018973.61359570662
2021-08-019644.454382826476
2021-09-019516.994633273704
2021-10-019313.506261180679
2021-11-018750.000000000002
2021-12-018012.075134168157
2022-01-017110.912343470483
2022-02-017267.441860465117
2022-03-015614.9373881932015
2022-04-014814.400715563506
2022-05-014861.359570661896
2022-06-014991.055456171735
2022-07-015223.613595706619
2022-08-015053.667262969589
2022-09-015322.003577817532
2022-10-016355.098389982111
2022-11-017052.772808586762
2022-12-016618.962432915921
2023-01-016934.257602862255
2023-02-017088.5509838998205
2023-03-016422.182468694096
2023-04-015737.924865831843
2023-05-016057.692307692308
2023-06-015809.481216457962
2023-07-015216.90518783542
2023-08-013991.502683363149
2023-09-014165.921288014311
2023-10-014360.46511627907
2023-11-014899.3738819320215
2023-12-015067.084078711985
2024-01-015259.391771019678
2024-02-015429.338103756709
2024-03-015679.785330948122
2024-04-015789.355992844365
2024-05-015735.688729874776
2024-06-015664.132379248657
2024-07-016093.470483005367
2024-08-015746.869409660107
2024-09-015523.2558139534885
2024-10-013826.0286225402506
2024-11-013962.432915921288
2024-12-013680.6797853309486
2025-01-013814.847942754919
2025-02-013902.0572450805007
2025-03-013360.912343470483
2025-04-013249.1055456171734
2025-05-012493.2915921288013
2025-06-012365.8318425760285
2025-07-011845.9302325581398
2025-08-012097.495527728086
2025-09-012101.9677996422183
2025-10-012180.232558139535
2025-11-012209.3023255813955
2025-12-012148.9266547406082
2026-01-012063.953488372093
2026-02-013211.091234347048
2026-03-013242.3971377459748
2026-04-013441.4132379248663
Annual Return Matrix
YearAnnual Return
20170.10110294117647056
2018-0.3765535151177889
20190.542695626301696
2020-0.12709739633558348
2021-0.2083517454706142
2022-0.17387663968741274
2023-0.23445945945945945
2024-0.27360988526037067
2025-0.4161603888213853
20260.6014568158168576
Total Factor Risk
0.4363314111963802
VTI.US Exposure
-0.0063995616655011375
VEA.US Exposure
0.14296589615606525
VWO.US Exposure
-0.027607227670169297
QQQ.US Exposure
0.031947250580219876
VTV.US Exposure
0.05616359422521206
IJR.US Exposure
0.12748136209115746
QUAL.US Exposure
0.18335163508291566
SHV.US Exposure
0.010303396732640855
TLT.US Exposure
0.0625647031143435
LQD.US Exposure
-0.0019919546417450193
HYG.US Exposure
0.016102987699641073
GLD.US Exposure
-0.005010413553562915
USO.US Exposure
0.002308453438372143
VNQ.US Exposure
-0.019224439192402056
BTC-USD.CC Exposure
-0.00037168739525364513
CPER.US Exposure
0.020976496173341838
VIX.INDX Exposure
-0.00046442153500461246
UUP.US Exposure
0.005017129776028438
TIP.US Exposure
0.024840503014708876
Idiosyncratic Exposure
0.37704629756899166
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
43.6%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$212.7M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+15.6%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+46.7%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
0.0% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.28
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Anika Therapeutics Inc a high-risk investment?

Anika Therapeutics Inc (ANIK.US) has an annualized volatility of 43.6% and experienced a maximum drawdown of 88.3% over the last 10 years. Its primary macro risk driver is QUAL.US.

What is the 10-year return of ANIK.US?

Over the past 10 years, ANIK.US has generated a Compound Annual Growth Rate (CAGR) of -10.7%. It has had a positive return in 30% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Anika Therapeutics Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest